Paradigm Shift for Evaluating, Treating Biochemical Recurrence in Prostate Cancer

By News Health
5 hours Ago

(MedPage Today) — Almost three-fourths of patients with biochemically recurrent prostate cancer remained metastasis free at 5 years following salvage radiotherapy (sRT) informed by prostate-specific membrane antigen (PSMA) PET/CT, a retrospective…

Source link : https://www.medpagetoday.com/hematologyoncology/prostatecancer/119814

Author :

Publish date : 2026-02-09 22:47:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Simple Question May Help Identify Women With Urinary Incontinence

NYC RNs Reach a Deal to End Strike at 2 Hospitals; Walkout Continues at Another

Daily Coffee Tied to Brain Benefits

Statin Adverse Event Labels May Be Overcautious, Analysis Suggests

Catherine O'Hara's Cause of Death Revealed

Cladribine a Safe ‘Exit Strategy’ for Stopping DMTs for MS